About Reprise Biomedical
Reprise Biomedical is a company based in Plymouth (United States) founded in 2019. Reprise Biomedical has raised $38.67 million across 5 funding rounds. The company has 16 employees as of December 31, 2022. Reprise Biomedical offers products and services including Miro3D, MiroDry, MiroTract, MiroDerm, and MiroFlex. Reprise Biomedical operates in a competitive market with competitors including MiMedx Group, pacifymedical, Hans Biomed, Rapid Graft and 3D Global Biotech, among others.
- Headquarter Plymouth, United States
- Employees 16 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$38.67 M (USD)
in 5 rounds
-
Latest Funding Round
$9.25 M (USD), Series B
May 14, 2026
-
Investors
Not available
-
Employee Count
16
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Reprise Biomedical
Reprise Biomedical offers a comprehensive portfolio of products and services, including Miro3D, MiroDry, MiroTract, MiroDerm, and MiroFlex.
Three-dimensional solution for deep and tunneling wound healing.
Device for managing advanced and complex wounds.
Product designed for targeted delivery to tunneling wounds.
Biologic matrix for skin wound repair and integration.
Flexible scaffold using decellularization for wound treatment.
People of Reprise Biomedical
Unlock access to complete
Unlock access to complete
Funding Insights of Reprise Biomedical
Reprise Biomedical has successfully raised a total of $38.67M across 5 strategic funding rounds. The most recent funding activity was a Series B round of $9.25 million completed in May 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by Reprise Biomedical
Investment portfolio details for Reprise Biomedical
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Reprise Biomedical
Detailed financials for Reprise Biomedical
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Reprise Biomedical Comparisons
Peer comparison for Reprise Biomedical
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Reprise Biomedical
Reprise Biomedical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as MiMedx Group, pacifymedical, Hans Biomed, Rapid Graft and 3D Global Biotech, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Regenerative biomaterial products and bioimplants for wound, surgical, sports medicine and orthopedics
|
|
| Locked | Locked | Locked |
Skin-spraying devices for advanced wound care are developed and manufactured.
|
|
| Locked | Locked | Locked |
Allograft tissues, biomaterials, and skin cell treatments are developed.
|
|
| Locked | Locked | Locked |
Split-skin grafts are developed for chronic wound treatment.
|
|
| Locked | Locked | Locked |
Developer of human tissues and organ reconstructed implants
|
Detailed competitors of Reprise Biomedical
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Reprise Biomedical
Complete news archive for Reprise Biomedical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Reprise Biomedical
Reprise Biomedical was founded in 2019 and raised its 1st funding round 1 year after it was founded.
Reprise Biomedical is headquartered in Plymouth, United States. It is registered at Plymouth, Massachusetts, United States.
Carrie Powers is the current CEO of Reprise Biomedical.
Reprise Biomedical is a funded company, having raised a total of $38.67M across 5 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Reprise Biomedical is 16.
Developer of surgical mesh for wound management. The products developed are FDA-approved MIRODERM (derived from the porcine liver) and MIROMESH (non-crosslinked acellular surgical mesh) that uses perfusion decellularization technology. It is used to treat wounds, ulcers, venous ulcers, chronic vascular ulcers, diabetic ulcers, tunneled and undermined wounds, trauma wounds, drainage wounds, and surgical wounds.
Reprise Biomedical's top competitors include MiMedx Group, pacifymedical and Hans Biomed.
Reprise Biomedical offers Miro3D, MiroDry, MiroTract, MiroDerm, and MiroFlex.